Sofia 2 Flu + SARS Antigen FIA

The Sofia 2 Flu + SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. The Sofia 2 Flu + SARS Antigen FIA with the Sofia 2 analyzer provides automated and objective results in 15 minutes, allowing for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care ( 25 tests/kit).

Item # 20377

This product is no longer available.

This Item is Non-Returnable

One sample, three results	Time savings, material conservation, and patient comfort.
Results in 15 minutes	Rapid results to support efficient dispositioning of patients.
Objective, accurate results	Reliable results without cross-reactivity to seasonal coronaviruses.
Dual work modes	Adjusts to your volume fluctuations. Allows for significant throughput and batching of samples in READ NOW Mode.
Easy to use	Seamless test workflow follows a similar format to CLIA-waived Sofia and Sofia 2 assays.
Virena connection	Provides automated tracking, data capture, government reporting, and exclusive disease mapping.
Fluorescent technology with automated read	Objective result that eliminates the subjectivity of a visual result.
All necessary components included in kit	Ready for use with Sofia 2 for nasal or nasopharyngeal swab procedure.
Self-contained Test Cassette	Clean, easy to use and dispose of.

Time to results	15 minutes
Sample type	Direct: Nasal swab, nasopharyngeal swab
Kit storage conditions	Room temperature (15°C to 35°C / 59°F to 86°F)
PPA (sensitivity)	Influenza A: NS - 90%, NPS - 97.1% Influenza B: NS - 89%, NPS - 90% SARS-CoV-2: 95.2%
NPA (specificity)	Influenza A: NS - 95%, NPS - 94.6% Influenza B: NS - 96%, NPS - 97% SARS-CoV-2: 100%
CLIA Complexity	Waived*

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days